Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Current Pharmaceutical Design|March 15, 2006
Coxibs and cardiovascular side-effects: from light to shadowJean-Michel Dogné, Julien Hanson, Claudiu Supuran, et al.Medicinal Research Reviews|September 21, 2007
Carbonic anhydrase IX: a new druggable target for the design of antitumor agentsJean-Yves Winum, Marouan Rami, Andrea Scozzafava, et al.Current Medicinal Chemistry. Cardiovascular and Hematological Agents|August 24, 2004
Progress in the field of GPIIb/IIIa antagonistsJulien Hanson, Xavier de Leval, Jean-Louis David, et al.Cancer Immunology, Immunotherapy : CII|February 8, 2011
Generation and characterization of the first inhibitory antibody targeting tumour-associated carbonic anhydrase XIIChristina Battke, Elisabeth Kremmer, Josef Mysliwietz, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|August 3, 2021
Carbonic anhydrase activation profile of indole-based derivativesElisabetta Barresi, Rahul Ravichandran, Lorenzo Germelli, et al.Oncotarget|August 11, 2015
Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer modelsCarol Ward, James Meehan, Peter Mullen, et al.Pageof 1